Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika M Kwon

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Molecular Cancer Research : MCR|March 14, 2015
Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic TestBrennan Decker, Heidi G Parker, Deepika Dhawan, et al.
Human Genetics|December 11, 2007
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 MbBo Johanneson, Shannon K McDonnell, Danielle M Karyadi, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2011
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortalityDaniel W Lin, Liesel M FitzGerald, Rong Fu, et al.
BMC Cancer|August 13, 2008
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancerLiesel M FitzGerald, Ilir Agalliu, Karynn Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 25, 2012
The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancerAbigail L Shearin, Benoit Hedan, Edouard Cadieu, et al.
Human Molecular Genetics|March 25, 2010
Fine scale mapping of the breast cancer 16q12 locusMiriam S Udler, Shahana Ahmed, Catherine S Healey, et al.
Nature Genetics|September 22, 2009
Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyRosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, et al.
Nature Genetics|July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyZsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Nature Genetics|March 29, 2013
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping arrayRosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|March 14, 2015
Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic TestBrennan Decker, Heidi G Parker, Deepika Dhawan, et al.
Human Genetics|December 11, 2007
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 MbBo Johanneson, Shannon K McDonnell, Danielle M Karyadi, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2011
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortalityDaniel W Lin, Liesel M FitzGerald, Rong Fu, et al.
BMC Cancer|August 13, 2008
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancerLiesel M FitzGerald, Ilir Agalliu, Karynn Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 25, 2012
The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancerAbigail L Shearin, Benoit Hedan, Edouard Cadieu, et al.
Human Molecular Genetics|March 25, 2010
Fine scale mapping of the breast cancer 16q12 locusMiriam S Udler, Shahana Ahmed, Catherine S Healey, et al.
Nature Genetics|September 22, 2009
Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyRosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, et al.
Nature Genetics|July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyZsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Nature Genetics|March 29, 2013
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping arrayRosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, et al.
Pageof 5